Skip to main content
. 2020 Oct 29;35(2):312–332. doi: 10.1038/s41375-020-01072-6

Fig. 5. Global trends in BTK inhibitors.

Fig. 5

A The indication distribution of BTK inhibitors in clinical trials of cancers; B The landscape of BTK inhibitors between 2005–2019; C The global status of BTK inhibitors in clinical trials of cancers.